Literature DB >> 26393316

Disturbed Th1 and Th2 balance in patients with Graves' disease.

Yeganeh Eshaghkhani1, Mohammad H Sanati, Manouchehr Nakhjavani, Reza Safari, Alireza Khajavi, Mitra Ataei, Zohreh Jadali.   

Abstract

BACKGROUND AND METHODS: Graves' disease (GD) is a common autoimmune disorder that is primarily driven by malfunction of T lymphocytes, which influences the production of antibodies reacting with cellular and tissue components of the thyroid gland. The aim of this study was to determine the level of mRNA expression for the genes encoding T-bet and GATA3, as the master regulators of the T helper (Th)1 and Th2 differentiation, respectively together with Th1 (IFN-γ) and Th2(IL-4) cytokine mRNA expression. Relative quantification of T-bet, GATA3, IFN-γ and IL-4 transcripts in peripheral blood mononuclear cell (PBMCs) was conducted by real-time reverse transcriptase PCR (RT-PCR). Serum levels of IFN-γ and IL-4 were also determined by Enzyme-linked immunosorbent assay (ELISA). In comparison with the normal group, T-bet and IFN-γ mRNA expression levels were significantly up-regulated in the GD patients, while GATA3 and IL-4 mRNA expression levels were downregulated. In addition, a marked decrease in plasma IL-4 levels was observed in the GD group. IFN-γ levels were also higher in patients in comparison to the controls. Furthermore, a clear correlation between increased IFN-γ mRNA expression and IFN-γ (P<0.05) was revealed. These results indicate that a Th1/Th2 imbalance exists in GD, and it may be implicated in the pathogenesis of disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26393316

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  7 in total

1.  A Global Regulatory Network for Dysregulated Gene Expression and Abnormal Metabolic Signaling in Immune Cells in the Microenvironment of Graves' Disease and Hashimoto's Thyroiditis.

Authors:  Haitao Zheng; Jie Xu; Yongli Chu; Wenzhou Jiang; Wenjie Yao; Shaowen Mo; Xicheng Song; Jin Zhou
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

2.  LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves' disease.

Authors:  Feng-Jiao Huang; Yan-Ling Liu; Jiao Wang; Ying-Ying Zhou; Shui-Ying Zhao; Gui-Jun Qin
Journal:  Cell Cycle       Date:  2022-02-27       Impact factor: 5.173

3.  Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases.

Authors:  Marta Rydzewska; Michał Jaromin; Izabela Elżbieta Pasierowska; Karlina Stożek; Artur Bossowski
Journal:  Thyroid Res       Date:  2018-02-13

4.  Decreased Expression of TIM-3 on Th17 Cells Associated with Ophthalmopathy in Patients with Graves' Disease.

Authors:  J Zhao; B Lin; H Deng; X Zhi; Y Li; Y Liu; P W Bible; Q Li; B Xu; L Wei; H Yang; D Huang
Journal:  Curr Mol Med       Date:  2018       Impact factor: 2.222

5.  Elevated Serum IL-17 Expression at Cessation Associated with Graves' Disease Relapse.

Authors:  Jianhui Li; Xiaohua Sun; Danzhen Yao; Jinying Xia
Journal:  Int J Endocrinol       Date:  2018-03-11       Impact factor: 3.257

6.  Application of red clover isoflavone extract as an adjuvant in mice.

Authors:  Hongbo Chen; Xue Zhang; Longsi Liu; Mingqin Cai; Zhijun Guo; Longxin Qiu
Journal:  Exp Ther Med       Date:  2019-12-11       Impact factor: 2.447

Review 7.  Genetics, Epigenetics, Cellular Immunology, and Gut Microbiota: Emerging Links With Graves' Disease.

Authors:  Fangyu Zhou; Xin Wang; Lingjun Wang; Xin Sun; Guiqin Tan; Wenwen Wei; Guangbing Zheng; Xiaomin Ma; Dan Tian; Hongsong Yu
Journal:  Front Cell Dev Biol       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.